Cargando…

Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic?

Coexistence of Crohn’s disease (CD) and idiopathic systemic lupus erythematosus (SLE) is very rare. On the other hand, drug-induced lupus erythematosus (DILE) due to anti-tumor necrosis factor (TNF) agents is a relatively more common entity. DILE due to anti-TNF agents and idiopathic SLE share commo...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalopoulos, George, Vrakas, Spyridon, Makris, Konstantinos, Tzathas, Charalampos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460384/
https://www.ncbi.nlm.nih.gov/pubmed/26126856
_version_ 1782375380059947008
author Michalopoulos, George
Vrakas, Spyridon
Makris, Konstantinos
Tzathas, Charalampos
author_facet Michalopoulos, George
Vrakas, Spyridon
Makris, Konstantinos
Tzathas, Charalampos
author_sort Michalopoulos, George
collection PubMed
description Coexistence of Crohn’s disease (CD) and idiopathic systemic lupus erythematosus (SLE) is very rare. On the other hand, drug-induced lupus erythematosus (DILE) due to anti-tumor necrosis factor (TNF) agents is a relatively more common entity. DILE due to anti-TNF agents and idiopathic SLE share common serologic and epidemiologic characteristics making the differentiation between those two entities difficult. We present a case of a 35-year-old woman with CD who developed SLE after treatment with adalimumab and denosumab and persisting symptoms eight months after discontinuation of those agents.
format Online
Article
Text
id pubmed-4460384
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hellenic Society of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-44603842015-07-01 Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic? Michalopoulos, George Vrakas, Spyridon Makris, Konstantinos Tzathas, Charalampos Ann Gastroenterol Case Report Coexistence of Crohn’s disease (CD) and idiopathic systemic lupus erythematosus (SLE) is very rare. On the other hand, drug-induced lupus erythematosus (DILE) due to anti-tumor necrosis factor (TNF) agents is a relatively more common entity. DILE due to anti-TNF agents and idiopathic SLE share common serologic and epidemiologic characteristics making the differentiation between those two entities difficult. We present a case of a 35-year-old woman with CD who developed SLE after treatment with adalimumab and denosumab and persisting symptoms eight months after discontinuation of those agents. Hellenic Society of Gastroenterology 2015 /pmc/articles/PMC4460384/ /pubmed/26126856 Text en Copyright: © Hellenic Society of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Michalopoulos, George
Vrakas, Spyridon
Makris, Konstantinos
Tzathas, Charalampos
Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic?
title Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic?
title_full Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic?
title_fullStr Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic?
title_full_unstemmed Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic?
title_short Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic?
title_sort systemic lupus erythematosus in crohn’s disease: drug-induced or idiopathic?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460384/
https://www.ncbi.nlm.nih.gov/pubmed/26126856
work_keys_str_mv AT michalopoulosgeorge systemiclupuserythematosusincrohnsdiseasedruginducedoridiopathic
AT vrakasspyridon systemiclupuserythematosusincrohnsdiseasedruginducedoridiopathic
AT makriskonstantinos systemiclupuserythematosusincrohnsdiseasedruginducedoridiopathic
AT tzathascharalampos systemiclupuserythematosusincrohnsdiseasedruginducedoridiopathic